IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

130 hedge funds and large institutions have $140M invested in iShares US Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 3 closing their positions.

Holders
130
Holders Change
+17
Holders Change %
+15.04%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
33
Reduced
32
Closed
3
Calls
$651K
Puts
$242K
Net Calls
+$409K
Net Calls Change
+$174K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$15.3M
2
RWP
2
RWA Wealth Partners
Massachusetts
$3.73M
3
Fisher Asset Management
3
Fisher Asset Management
Washington
$7.21M
4
Goldman Sachs
4
Goldman Sachs
New York
$4.05M
5
Citadel Advisors
5
Citadel Advisors
Florida
$5.18M

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$7.05M
2
CCT
2
Chemung Canal Trust
New York
$572K
3
FMP
3
Financial Management Professionals
Texas
$15K
4
TRCT
4
Tower Research Capital (TRC)
New York
$109K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$8.06M
Name Holding Trade Value Shares
Change 		Shares
Change %
CWC
126
Carolinas Wealth Consulting
North Carolina
$1.49K – – –
NSIM
127
North Star Investment Management
Illinois
$1.36K – – –
TFA
128
Transamerica Financial Advisors
Florida
$1K – – –
RG
129
Retirement Group
California
$1K +$1K +12 New
HNB
130
Huntington National Bank
Ohio
$186 – – –
NA
131
NewEdge Advisors
Louisiana
$84 +$84 +1,347 New
AIP
132
Almanack Investment Partners
Pennsylvania
– -$17K -300 Closed
S
133
SignatureFD
Georgia
– -$8K -150 Closed
CAAS
134
Capital Asset Advisory Services
Michigan
– -$1K -9 Closed
2 3 4 5
6